The Truth Will Out (And It Should)

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

Karl Smith:

To my mind there are few things that tax intellectual ethics more profoundly than whether the psychotropic debate should be had in public. It is my general feeling that it should not.

My blog is not read by the general public but I will make no attempt to be transparent. Those in the know, know what I am talking about.

Hmmm. I don’t know for sure what Karl is referring to, but I assume he’s talking about the ongoing debate over whether or not psychoactive drugs like antidepressants actually work. There’s a growing body of evidence that they don’t — at least not the way we think they do. Rather, they’re mostly very expensive placebos.

Is this dangerous to talk about in public? Sure, to some extent. After all, relief is relief, regardless of whether it’s caused by a known biologic reaction or by a more mysterious placebo effect. If you had a friend who was taking, say, Prozac, and they reported feeling a lot better, would you take them aside and inform them that research suggests Prozac is nothing more than a complicated sugar pill and their response is probably just a placebo effect? Sure, if you’re an asshole. After all, telling them this has a good chance of making their belief in the drug vanish, and they’ll go back to feeling crappy. Nice work, alleged friend!

But that’s quite a different thing from discussing this as a general topic in public forums. Here’s the problem: there are enormous commercial forces pushing to make sure that we all continue to think these drugs work, and a non-public discussion is almost certain to be far less effective than a public discussion at applying pressure for change. Without public pressure, we’ll get an endless faux-analytic debate in industry circles that’s dominated far more than anyone wants to admit by the financial interests of the drug makers. Their ability to control these debates by selective release of data, financial incentives to researchers and doctors, and sophisticated industry marketing campaigns aimed at physicians, is hardly a secret.

My take on the historical record is that it usually takes public pressure — and plenty of it — to really move the needle on this stuff. There are just too many powerful industry interests fighting to maintain their financial stakes and willing to manufacture endless doubt about results they don’t like. Examples of this are simply legion. So if we want to get to the truth of this — and in the long term, that’s the most helpful thing we can do for everyone — we need to have this debate in public. It’s messy, but the net result will be for the best.

IT'S NOT THAT WE'RE SCREWED WITHOUT TRUMP:

"It's that we're screwed with or without him if we can't show the public that what we do matters for the long term," writes Mother Jones CEO Monika Bauerlein as she kicks off our drive to raise $350,000 in donations from readers by July 17.

This is a big one for us. It's our first time asking for an outpouring of support since screams of FAKE NEWS and so much of what Trump stood for made everything we do so visceral. Like most newsrooms, we face incredibly hard budget realities, and it's unnerving needing to raise big money when traffic is down.

So, as we ask you to consider supporting our team's journalism, we thought we'd slow down and check in about where Mother Jones is and where we're going after the chaotic last several years. This comparatively slow moment is also an urgent one for Mother Jones: You can read more in "Slow News Is Good News," and if you're able to, please support our team's hard-hitting journalism and help us reach our big $350,000 goal with a donation today.

payment methods

IT'S NOT THAT WE'RE SCREWED WITHOUT TRUMP:

"It's that we're screwed with or without him if we can't show the public that what we do matters for the long term," writes Mother Jones CEO Monika Bauerlein as she kicks off our drive to raise $350,000 in donations from readers by July 17.

This is a big one for us. So, as we ask you to consider supporting our team's journalism, we thought we'd slow down and check in about where Mother Jones is and where we're going after the chaotic last several years. This comparatively slow moment is also an urgent one for Mother Jones: You can read more in "Slow News Is Good News," and if you're able to, please support our team's hard-hitting journalism and help us reach our big $350,000 goal with a donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate